Sapreme Technologies

Bilthoven, The Netherlands

Sapreme Technologies is a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutic.

$17.3M raised

Oct 2021

Series A

Biotechnology Life Science Pharmaceutical

Top Investors

Aglaia BioMedical Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sapreme Technologies

How much funding has Sapreme Technologies raised?

Sapreme Technologies has raised $17.3M in total funding. The most recent round was Series A. The last funding was announced in October 2021.

Who are Sapreme Technologies's investors?

Sapreme Technologies's investors include Aglaia BioMedical Ventures.

Where is Sapreme Technologies headquartered?

Sapreme Technologies is headquartered in Bilthoven, The Netherlands.

What does Sapreme Technologies do?

Sapreme Technologies is a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutic.

What stage is Sapreme Technologies at?

Sapreme Technologies is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 7, 2021.

MLA

"Sapreme Technologies — Funding & Investors." VCBacked, October 7, 2021, https://www.vcbacked.co/company/sapreme-technologies. Accessed July 2, 2026.

APA

VCBacked. (2021). Sapreme Technologies — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/sapreme-technologies

Wikipedia (cite web)

{{cite web |title=Sapreme Technologies — Funding & Investors |url=https://www.vcbacked.co/company/sapreme-technologies |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 7, 2021.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K